Facebook Twitter Tumblr Close Skip to main content
A Project of The Annenberg Public Policy Center

Yale Preprint Recorded Patient Experiences, Did Not Demonstrate Vaccines Cause New Syndrome

Yale Preprint Recorded Patient Experiences, Did Not Demonstrate Vaccines Cause New Syndrome

A preprint on a Yale-based study described chronic symptoms self-reported after COVID-19 vaccination by 241 members of an online group. The paper, which has not been peer-reviewed, did not show how common these symptoms are in the general population, nor whether vaccinations caused them — limitations popular online posts did not make clear.

Posts Exaggerate Significance of Swiss Study on Heart Risk and COVID-19 Vaccination

Posts Exaggerate Significance of Swiss Study on Heart Risk and COVID-19 Vaccination

A Swiss study found that after a COVID-19 booster, less than 3% of people briefly had a slightly elevated blood level of a protein that can be a marker of heart injury. No one in the study had any serious heart damage, and other experts say the findings are unlikely to be clinically significant. Viral posts, however, are spinning the results to falsely claim that the study shows the vaccine’s risks are “off the scale.”

Posts Misinterpret Pfizer COVID-19 Vaccine Safety Monitoring Document

Posts Misinterpret Pfizer COVID-19 Vaccine Safety Monitoring Document

A Pfizer document recently released by the Food and Drug Administration describes adverse events reported following vaccination and attests to the continued safety of the company’s COVID-19 vaccine. A popular video and other online posts, however, incorrectly imply that the vaccine caused the events.

Evidence Still Lacking to Support Ivermectin as Treatment for COVID-19

Evidence Still Lacking to Support Ivermectin as Treatment for COVID-19

Randomized controlled trials haven’t found ivermectin is beneficial in treating COVID-19, although results for ongoing studies will provide a more definitive answer. Yet, a video presents two weak studies as “powerful” and “overwhelming” evidence that the medication works to combat COVID-19.